MedPath

Hydronephrosis ARFI Study

Not Applicable
Completed
Conditions
Hydronephrosis
Interventions
Procedure: AFRI-SVI Ultrasound
Registration Number
NCT01781845
Lead Sponsor
University of Michigan
Brief Summary

Pediatric upper urinary tract dilatation (hydronephrosis) is relatively common and may be either obstructive or nonobstructive. While the upper urinary tract is commonly evaluated by ultrasound, this imaging technique often fails to distinguish obstructed from nonobstructed systems. ARFI SVI is a new ultrasound technology that can be used to determine stiffness by measuring a tissue's shear wave velocity, may show alterations in parenchymal shear wave velocity in kidneys that show obstruction on DRS (Diuretic renal scintigraphy)which serves as the reference standard.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  1. 18 years of age or younger
  2. You are scheduled for diuretic scintigraphy (DRS)testing -
Read More
Exclusion Criteria

None

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ARFI-SVI UltrasoundAFRI-SVI UltrasoundUltrasound scan using acoustic radiation force impulse-shear wave velocity imaging in the characterization of pediatric hydronephrosis. This is a non-invasive scan that uses sound waves to create the images.
Primary Outcome Measures
NameTimeMethod
ARFI-SVI6 months

fibrosis and intratubular pressure will be evidenced by higher parenchymal shear wave velocity measurements using the ARFI-SVI technology.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Michigan Hospital

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath